What is Azenta's cash & equivalents?

Azenta (AZTA) reported cash & equivalents of $125.19M in Q1 2026.

What is the long-term trend for Azenta's cash & equivalents?

Over 4 years (2020 to 2025), Azenta's cash & equivalents has grown at a -12.1% compound annual growth rate (CAGR), from $250.65M to $149.79M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Azenta AZTA Cash & Equivalents

Cash & Equivalents at other companies

Thermo Fisher ScientificTMO

$3.28B-21.4%

DanaherDHR

$5.7B+186%

Labcorp HoldingsLH

$981.1M+166%

IlluminaILMN

$1.09B-2.2%

CryoPort, Inc.CYRX

$272.91M+656%

Twist Bioscience CorporationTWST

$124.85M-41.4%

Other financials

Income statement

See full

Revenue$144.8M+1.0%

Gross profit$62.0M-1.2%

Operating income-$165.8M-811%

Net income-$160.8M-237%

EPS (diluted)-$3.49-236%

Balance sheet

See full

Total debt$55.7M—

Total equity$1.6B-8.3%

Total assets$1.9B—

Cash flow

See full

Operating cash flow$13.5M-6.2%

CapEx$7.4M-0.1%

Free cash flow$6.1M-12.7%

Valuation

See full

Market cap$1.1B-19.0%

Enterprise value$1.03B—

P/S1.8×-0.3×

Profitability

See full

Gross margin40%-1.0pp

Operating margin-31.6%-59.7pp

Net margin-29.1%-80.7pp

FCF margin8.6%—

Returns & leverage

See full

Return on equity-10.7%-22.4pp

Debt / equity0×—

Current ratio2.8×—

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsFairValueDisclosure.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Azenta's cash & equivalents?: Azenta (AZTA) reported cash & equivalents of $125.19M in Q1 2026.
What is the long-term trend for Azenta's cash & equivalents?: Over 4 years (2020 to 2025), Azenta's cash & equivalents has grown at a -12.1% compound annual growth rate (CAGR), from $250.65M to $149.79M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.